It has been suggested that parasitic infections, common in Latin American populations, may amplify the inflammatory response of the airways. There are several reports of atopic and asthmatic patients but few reports of parasitic infection in COPD patients. This study aimed to determine the prevalence of parasitic infections in COPD patients compared with atopic and asthmatic patients attending the Institute of Immunology outpatient clinics and the pneumology service of the University hospital. A case-control study was conducted compising 100 patients with bronchial asthma, 100 patients with COPD, 100 individuals with atopy without respiratory symptoms, and 100 healthy individuals. Serum-specific IgG antibodies against the parasites Ascaris lumbricoides (Al), Strongyloides stercolaris (Ss), and Toxocara canis (Tc) were measured by ELISA. IgE levels were used as an indirect indicator of atopy. Positive IgG for Al was observed in all groups, predominantly in the atopic cohort; Ss positiveness was recorded only in four COPD patients, and Tc positiveness was observed in all groups except in controls. Significant correlations exist between the values of Al and IgE in controls, atopic, and asthmatic patients without COPD. No correlation was found for Tc. IgE levels and the forced expiratory volume in 1 s (FEV1) correlate only in atopic and asthmatic patients. Parasitic infections are common in atopic patients and moderate and severe asthmatic and COPD patients. Anti-inflammatory treatment may be responsible for the increased frequency of infection in moderate and severe asthmatic and COPD patients.

Chair of Physiopathology Luis Razetti School of Medicine Faculty of Medicine Universidad Central de Venezuela Caracas 1050 Venezuela

Institute of Immunology Dr Nicolás E Bianco Faculty of Medicine Universidad Central de Venezuela Caracas 1050 Venezuela

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Hněvotínská 1333 5 77900 Olomouc Czech Republic

Zobrazit více v PubMed

Manian P. Chronic obstructive pulmonary disease classification, phenotypes, and risk assessment. J. Thorac. Dis. 2019;11((Suppl. S14)):S1761–S1766. doi: 10.21037/jtd.2019.05.10. PubMed DOI PMC

COPD Foundation. [(accessed on 9 August 2024)]. Available online: https://www.copdfoundation.org/

GOLD Report Guidelines for COPD. [(accessed on 31 August 2024)]. Available online: https://goldcopd.org/2024-gold-report/

Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008;8:183–192. doi: 10.1038/nri2254. PubMed DOI

Chung K.F., Pavord I.D. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008;371:1364–1374. doi: 10.1016/S0140-6736(08)60595-4. PubMed DOI

Polverino F., Sin D.D. Type 2 airway inflammation in COPD. Eur. Respir. J. 2024;63:2400150. doi: 10.1183/13993003.00150-2024. PubMed DOI

Singh D. Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects. Tuberc. Respir. Dis. 2020;83:185–194. doi: 10.4046/trd.2020.0026. PubMed DOI PMC

Liu H., Xie Y., Huang Y., Luo K., Gu Y., Zhang H., Xu Y., Chen X. The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respir. Med. 2024;222:107501. doi: 10.1016/j.rmed.2023.107501. PubMed DOI

Higham A., Beech A., Singh D. The relevance of eosinophils in chronic obstructive pulmonary disease: Inflammation, microbiome and clinical outcomes. J. Leuk. Biol. 2024;23:qiae153. doi: 10.1093/jleuko/qiae153. PubMed DOI

Global Strategy for Asthma Management and Prevention (GINA) [(accessed on 9 August 2024)]. Available online: www.ginasthma.org.

Hashmi M.F., Cataletto M.E. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2024. [(accessed on 3 May 2024)]. Asthma. Available online: https://www.ncbi.nlm.nih.gov/books/NBK430901/

Justiz Vaillant A.A., Modi P., Jan A. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2024. [(accessed on 8 June 2024)]. Atopy. Available online: https://www.ncbi.nlm.nih.gov/books/NBK542187/

Trivedi M., Denton E. Asthma in Children and Adults-What Are the Differences and What Can They Tell us About Asthma? Front. Pediatr. 2019;7:256. doi: 10.3389/fped.2019.00256. PubMed DOI PMC

Espuela-Ortiz A., Martin-Gonzalez E., Poza-Guedes P., González-Pérez R., Herrera-Luis E. Genomics of Treatable Traits in Asthma. Genes. 2023;14:1824. doi: 10.3390/genes14091824. PubMed DOI PMC

Herrera-Luis E., Martin-Almeida M., Pino-Yanes M. Asthma-Genomic Advances Toward Risk Prediction. Clin. Chest Med. 2024;45:599–610. doi: 10.1016/j.ccm.2024.03.002. PubMed DOI PMC

Ishmael L., Casale T., Cardet J.C. Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma. Biology. 2024;13:583. doi: 10.3390/biology13080583. PubMed DOI PMC

Leung A.K.C., Leung A.A.M., Wong A.H.C., Hon K.L. Human Ascariasis: An Updated Review. Recent. Pat. Inflamm. Allergy Drug Dis. 2020;14:133–145. doi: 10.2174/1872213X14666200705235757. PubMed DOI

Hon K.L., Leung A.K.C. An update on the current and emerging pharmacotherapy for the treatment of human ascariasis. Expert Opin. Pharmacother. 2024 doi: 10.1080/14656566.2024.2319686. accepted . PubMed DOI

Jõgi N.O., Kitaba N., Storaas T., Schlünssen V., Triebner K., Holloway J.W., Horsnell W.G.C., Svanes C., Bertelsen R.J. Ascaris exposure and its association with lung function, asthma, and DNA methylation in Northern Europe. J. Aller Clin. Immunol. 2022;149:1960–1969. doi: 10.1016/j.jaci.2021.11.013. PubMed DOI

O’Connell E.M., Nutman T.B. Eosinophilia in Infectious Diseases. Immunol. Allergy Clin. N. Am. 2015;35:493–522. doi: 10.1016/j.iac.2015.05.003. PubMed DOI PMC

Jackson D.J., Akuthota P., Roufosse F. Eosinophils and eosinophilic immune dysfunction in health and disease. Eur. Respir. Rev. 2022;31:210150. doi: 10.1183/16000617.0150-2021. PubMed DOI PMC

Nóbrega C., Nascimento W., Lorena V., Medeiros D., Costa V., Albuquerque M., Barbosa C., Solé D., Sarinho E., Souza V. Cellular immune response of asthmatic children in the presence of anti-Ascaris antibody. Immunobiology. 2020;225:151978. doi: 10.1016/j.imbio.2020.151978. PubMed DOI

Buonfrate D., Bradbury R.S., Watts M.R., Bisoffi Z. Human strongyloidiasis: Complexities and pathways forward. Clin. Microbiol. Rev. 2023;36:e0003323. doi: 10.1128/cmr.00033-23. PubMed DOI PMC

Jacob L., Basu A., Paul D., Ray Y., Begam N.N., John C.V. Strongyloides stercoralis hyperinfection syndrome. Lancet Infect. Dis. 2024;24:e601. doi: 10.1016/S1473-3099(24)00417-1. PubMed DOI

Salam R., Sharaan A., Jackson S.M., Solis R.A., Zuberi J. Strongyloides Hyperinfection Syndrome: A Curious Case of Asthma Worsened by Systemic Corticosteroids. Am. J. Case Rep. 2020;21:e925221. doi: 10.12659/AJCR.925221. PubMed DOI PMC

Barkati S., Greenaway C., Libman M. Strongyloidiasis-related lung involvement: Too much of a bad thing. Curr. Opin. Infect. Dis. 2023;36:203–208. doi: 10.1097/QCO.0000000000000915. PubMed DOI

Alam A.M., Ozdemir C., Reza N. Strongyloides stercoralis infection in the UK: A systematic review and meta-analysis of published cases. Clin. Med. 2024;24:100227. doi: 10.1016/j.clinme.2024.100227. PubMed DOI PMC

Rostami A., Ma G., Wang T., Koehler A.V., Hofmann A., Chang B.C.H., Macpherson C.N., Gasser R.B. Human toxocariasis—A look at a neglected disease through an epidemiological ‘prism’. Infect. Genet. Evol. 2019;74:104002. doi: 10.1016/j.meegid.2019.104002. PubMed DOI

Auer H., Walochnik J. Toxocariasis and the clinical spectrum. Adv. Parasitol. 2020;109:111–130. doi: 10.1016/bs.apar.2020.01.005. PubMed DOI

Henke K., Ntovas S., Xourgia E., Exadaktylos A.K., Klukowska-Rötzler J., Ziaka M. Who Let the Dogs Out? Unmasking the Neglected: A Semi-Systematic Review on the Enduring Impact of Toxocariasis, a Prevalent Zoonotic Infection. Inter. J. Environ. Res. Public Health. 2023;20:6972. doi: 10.3390/ijerph20216972. PubMed DOI PMC

Pinelli E., Aranzamendi C. Toxocara infection and its association with allergic manifestations. Endocr. Metab. Immune Disord. Drug Targets. 2012;12:33–44. doi: 10.2174/187153012799278956. PubMed DOI

Ranasuriya G., Mian A., Boujaoude Z., Tsigrelis C. Pulmonary toxocariasis: A case report and literature review. Infection. 2014;42:575–578. doi: 10.1007/s15010-014-0587-3. PubMed DOI

Debnath S.K., Debnath M., Srivastava R. Opportunistic etiological agents causing lung infections: Emerging need to transform lung-targeted delivery. Heliyon. 2022;8:e12620. doi: 10.1016/j.heliyon.2022.e12620. PubMed DOI PMC

Lamberton P.H., Jourdan P.M. Human Ascariasis: Diagnostics Update. Curr. Trop. Med. Rep. 2015;2:189–200. doi: 10.1007/s40475-015-0064-9. PubMed DOI PMC

Tarafder M.R., Carabin H., Joseph L., Balolong E., Jr., Olveda R., McGarvey S.T. Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a ‘gold standard’. Int. J. Parasitol. 2010;40:399–404. doi: 10.1016/j.ijpara.2009.09.003. PubMed DOI PMC

Machicado J.D., Marcos L.A., Tello R., Canales M., Terashima A., Gotuzzo E. Diagnosis of soil-transmitted helminthiasis in an Amazonic community of Peru using multiple diagnostic techniques. Trans. R. Soc. Trop. Med. Hyg. 2012;106:333–339. doi: 10.1016/j.trstmh.2012.03.004. PubMed DOI

Mitchell J.R. Detection of Toxacara canis Antibodies With Fluorescent Antibody Technique. Proc. Soc. Exp. Biol. Med. 1964;117:267–270. doi: 10.3181/00379727-117-29554. PubMed DOI

Jacquier P., Gottstein B., Stingelin Y., Eckert J. Immunodiagnosis of toxocarosis in humans: Evaluation of a new enzyme-linked immunosorbent assay kit. J. Clin. Microbiol. 1991;29:1831–1835. doi: 10.1128/jcm.29.9.1831-1835.1991. PubMed DOI PMC

Del Pilar Fortes M., Gill G., Paredes M.E., Gamez L.E., Palacios M., Blanca I., Tassinari P. Allele and haplotype frequencies at human leukocyte antigen class I and II genes in Venezuela’s population. Ann. Biol. Clin. 2012;70:175–181. doi: 10.1684/abc.2012.0663. PubMed DOI

Schoos A.M. Atopic diseases-Diagnostics, mechanisms, and exposures. Pediatr. Allergy Immunol. 2024;35:e14198. doi: 10.1111/pai.14198. PubMed DOI

Lau S.K., Woo P.C., Wong S.S., Ma E.S., Yuen K.Y. Ascaris-induced eosinophilic pneumonitis in an HIV-infected patient. J. Clin. Pathol. 2007;60:202–203. doi: 10.1136/jcp.2006.037267. PubMed DOI PMC

Hanh N.T.L., Lee Y.L., Lin C.L., Chou C.M., Cheng P.C., Quang H.H., Fan C.K. Evidence for Asthma in the Lungs of Mice Inoculated with Different Doses of Toxocara canis. Am. J. Trop. Med. Hyg. 2020;103:2305–2314. doi: 10.4269/ajtmh.20-0484. PubMed DOI PMC

Vallentin B., Carsin A., Dubus J.C. Toxocariasis: An unusual cause of pleural effusion. Pediatr. Pulmonol. 2015;50:E35–E36. doi: 10.1002/ppul.23192. PubMed DOI

Bohnacker S., Troisi F., de Los Reyes Jiménez M., Esser-von Bieren J. What Can Parasites Tell Us About the Pathogenesis and Treatment of Asthma and Allergic Diseases. Front. Immunol. 2020;11:2106. doi: 10.3389/fimmu.2020.02106. PubMed DOI PMC

Caraballo L., Llinás-Caballero K. The Relationship of Parasite Allergens to Allergic Diseases. Curr. Allergy Asthma Rep. 2023;23:363–373. doi: 10.1007/s11882-023-01089-8. PubMed DOI PMC

Ahumada V., García E., Dennis R., Rojas M.X., Rondón M.A., Pérez A., Peñaranda A., Barragán A.M., Jimenez S., Kennedy M.W., et al. IgE responses to Ascaris and mite tropomyosins are risk factors for asthma. Clin. Exp. Allergy. 2015;45:1189–1200. doi: 10.1111/cea.12513. PubMed DOI

Matucci A., Vultaggio A., Maggi E., Kasujee I. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir. Res. 2018;19:113. doi: 10.1186/s12931-018-0813-0. PubMed DOI PMC

Guida G., Bertolini F., Carriero V., Levra S., Sprio A.E., Sciolla M., Orpheu G., Arrigo E., Pizzimenti S., Ciprandi G., et al. Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes. J. Clin. Med. 2023;12:5447. doi: 10.3390/jcm12175447. PubMed DOI PMC

Toychiev A., Gafner N., Belotserkovets V., Sekler D., Tashpulatova S., Osipova S. Impact of Ascaris lumbricoides infection on the development of chronic pulmonary aspergillosis in patients with COPD. Trop Doct. 2024;54:149–156. doi: 10.1177/00494755241226488. PubMed DOI

Ahmed N.J., Husen A.Z., Khoshnaw N., Getta H.A., Hussein Z.S., Yassin A.K., Jalal S.D., Mohammed R.N., Alwan A.F. The Effects of Smoking on IgE, Oxidative Stress and Haemoglobin Concentration. Asian Pac. J. Cancer Prev. 2020;21:1069–1072. doi: 10.31557/APJCP.2020.21.4.1069. PubMed DOI PMC

Maetani T., Tanabe N., Sato A., Shiraishi Y., Sakamoto R., Ogawa E., Sakai H., Matsumoto H., Sato S., Date H., et al. Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD. ERJ Open Res. 2023;9:00235–02023. doi: 10.1183/23120541.00235-2023. PubMed DOI PMC

Tan L.D., Schaeffer B., Alismail A. Parasitic (Helminthic) Infection While on Asthma Biologic Treatment: Not Everything Is What It Seems. J. Asthma Allergy. 2019;12:415–420. doi: 10.2147/JAA.S223402. PubMed DOI PMC